Renal Cancer - Results from #5720

Tumor control with PD-1 inhibition in a patient with concurrent metastatic melanoma and renal cell carcinoma April 28, 2016

Prospective MR image alignment between breath-holds: Application to renal BOLD MRI April 28, 2016

Loss of Fumarate Hydratase and Aberrant Protein Succination Detected With S-(2-Succino)-Cysteine Staining to Identify Patients With Multiple Cutaneous and Uterine Leiomyomatosis and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome April 28, 2016

Renal cell carcinoma: Are we attacking a different tumor over the past 10 years? April 27, 2016

Impact of Second-Line Targeted Therapy Dose Intensity on Patients With Metastatic Renal Cell Carcinoma April 27, 2016

Dual Roles of 17-β Estradiol in Estrogen Receptor-dependent Growth Inhibition in Renal Cell Carcinoma. April 26, 2016

SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis April 26, 2016

The Evolution of Nephrectomy and Patient Characteristics in Metastatic Renal Cell Carcinoma Patients Enrolled Into First-Line Tyrosine Kinase Inhibitors Clinical Trials April 26, 2016

Targeted dual-modality imaging in renal cell carcinoma: An ex vivo kidney perfusion study April 26, 2016

FDA Approves Cabozantinib Tablets For Patients with Advanced Renal Cell Carcinoma Who Have Received Prior Anti-angiogenic Therapy April 25, 2016

Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution April 25, 2016

Trends in the use of partial nephrectomy for cT1 renal tumors: Analysis of a 10-yr European multicenter dataset April 25, 2016

Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project April 25, 2016

Renal Cell Carcinoma Presenting as Radiating Rib Pain: A 65-Year-Old Woman April 24, 2016

Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis April 24, 2016

Safety and clinical activity of vascular endothelial growth factor receptor (VEGFR)- tyrosine kinase inhibitors after programmed cell death 1 inhibitor treatment in patients with metastatic clear cell renal cell carcinoma April 24, 2016

Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment April 24, 2016

SnapShot: Renal Cell Carcinoma April 23, 2016

Sunitinib-induced thrombotic microangiopathy April 22, 2016

Long-Term Renal Outcomes after Cisplatin Treatment April 22, 2016

Page 287 of 456